Parallax Health Sciences Inc (PRLX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access PRLX Annual Cash Flow →
A period-by-period view of cash flow from Parallax Health Sciences Inc to Dec 31 2018 helps clarify how Dec 31 2019's cash position has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2019)
12 Months
(Sep 30 2019) (Jun 30 2019) (Mar 31 2019) (Dec 31 2018)
Operating Activities
Income-12.87
Depreciation & amortization0.19
Amortization of Other Assets0.00
Accretion Expense0.18
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation2.78
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.81
Conversion Of Accounts Payable Into Common Stock-
Debt Conversion Original Debt Amount-
Conversion Of Related Party Payables To Non Related Party Payables-
Stock Issued During Period Value Purchase Of Assets-
Noncash Or Part Noncash Acquisition Debt Assumed-
Noncash Or Part Noncash Acquisition Value Of Assets Acquired-
Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed-
Treasury Stock Retired Par Value Method Amount-
Discount Amortization-0.02
Allowance For Loan And Lease Loss Recovery Of Bad Debts-
Gain On Disposal Of Subsidairy-
Gain Loss Related To Litigation Settlement0.14
Tangible Asset Impairment Charges-0.50
Securities Received In Exchange For License Fee-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts and Other Receivables0.00
Accounts Payable0.93
Increase (Decrease) in Pension Plan Obligations0.00
Increase (Decrease) in Security Deposits-0.01
Increase (Decrease) in Prepaid Expense0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities2.57
Discontinued operations0.00
Net Cash flow from Operating Activities0.00
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net-0.42
Other borrowing transactions0.00
Long-term debt - borrowings1.59
Long-term debt - repayments-0.55
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock2.34
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.07
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Shareholders-
Cash Received Upon Merger-
Subscription Payment-
Proceeds From Issuance Of Common Shares For Acquisition-
Proceeds From Issuance Of Common Shares For Acquisition Of Intangible Assets-
Proceeds From Issuance Of Common Shares For Acquisition Of Intangible Asset-
Short Term Lease Payments-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities2.95
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow0.00
Total Cash Flow0.01
4 historic quarters locked

Sign in to unlock the full Parallax Health Sciences Inc cash flow history.

About PRLX Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.